Capulus Therapeutics, headquartered in San Francisco, USA with operations in India, is pioneering innovative cancer therapies. We leverage a unique AI-driven strategy that integrates computational chemistry and structure-based drug design to discovery new medicines. We are actively developing a robust pipeline of oncology programs, with a separate pipeline focused on metabolic disease.
Company Details
- Address
- 535 Mission St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.capulustx.com
- HQ
- San Francisco, California
Capulus Therapeutics Questions
Capulus Therapeutics's website is http://www.capulustx.com
Capulus Therapeutics's LinkedIn profile is https://www.linkedin.com/company/capulustx
Capulus Therapeutics's industry is
Biotechnology Research
Capulus Therapeutics's top competitors are
Auron Therapeutics, Inc.,
Volastra Therapeutics,
Evolveimmune Therapeutics,
Differentiated Therapeutics Inc,
Rgenta Therapeutics Inc.,
Aptose Biosciences, Inc.,
Parabilis Medicines.
Capulus Therapeutics's categories are Biotechnology Research
